Tangent90 enables pharma to drive better access and ongoing engagement with healthcare professionals using innovative digital solutions to distribute and support communication of scientific copyright content. Utilising our extensive knowledge of the life sciences industry and working with a network of partners we trust and who trust us, we offer unique solutions which focus on removing hurdles for effective communication such as copyright and publisher term and condition compliance, regulatory requirements, ease of use and ease of access. We go beyond expectation – continually enhancing the solution to incorporate new and innovative channels, working with publishers to deliver new content discovery capabilities, and delivering approaches to increase efficiency. Together we deliver fast, cost-effective, compliant distribution of scientific content that meets the needs of HCPs, and enables the pharmaceutical industry to manage efficiencies and drive successful customer engagement.
Looking for a particular Tangent90 Ltd employee's phone or email?
The Tangent90 Ltd annual revenue was $6.5 million in 2026.
Jan van Den Burg is the CEO of Tangent90 Ltd.
16 people are employed at Tangent90 Ltd.
The NAICS codes for Tangent90 Ltd are [517, 5171, 51711, 513, 517110, 51].
The SIC codes for Tangent90 Ltd are [7375, 737, 73].